Chugai Pharmaceutical Co Ltd
OTC:CHGCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Chugai Pharmaceutical Co Ltd (CHGCY) under the Base Case is USD per share.
Compared with the current market price of 22.18 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Chugai Pharmaceutical Does
Chugai Pharmaceutical is a Japanese drug company that discovers, develops, manufactures, and sells prescription medicines. Its main products are treatments for cancer, immune diseases, blood disorders, bone and joint conditions, and other serious illnesses. The company is focused on medicines that doctors prescribe and hospitals use, not consumer health products.
- Headquarters
- Japan JP
- Employees
- 5 104
- IPO date
- Mar 3, 1956
Chugai Pharmaceutical has a narrow economic moat
Patent protection prevents rivals from freely copying Chugai’s medicines and the antibody technologies used to develop them. Drugs such as Hemlibra turn that protection into sales and licensing income, while its protected research technologies also support the development of new treatments.
Read the full moat analysis
Revenue & Expenses Breakdown
Chugai Pharmaceutical Co Ltd
Earnings Waterfall
Chugai Pharmaceutical Co Ltd
What is the Intrinsic Value of one CHGCY stock?
The intrinsic value for Chugai Pharmaceutical Co Ltd (CHGCY) under the Base Case is USD.
Is CHGCY stock undervalued or overvalued?
Compared with the current market price of 22.18 USD, the stock appears .
